Jiangsu Kanion Pharmaceutical Co.,Ltd.’s Net Profit Rose 36.2% in 2022

Jiangsu Kanion Pharmaceutical Co.,Ltd. (江苏康缘药业股份有限公司) (600557.SH) reported a net profit of 441.9 million yuan in 2022, up 36.2% year-on-year.

Meanwhile, the company posted 4.4 billion yuan in revenue, up 19.2% year-on-year.

At the end of the reporting period, it had 6.8 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 27.4%.